tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
EVAX
Evaxion Biotech
RESEARCH TOOLSreports
Want to see EVAX full AI Analyst Report?

Evaxion Biotech (EVAX) Income Statement

403 Followers

Evaxion Biotech Income Statement

Last quarter (Q4 2025), Evaxion Biotech's total revenue was $22.04K, an increase of Infinity% from the same quarter last year. In Q4, Evaxion Biotech's net income was $-5.94M. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 7.55M$ 3.34M$ 73.00K$ 0.00$ 0.00
Gross Profit
$ 7.53M$ 3.34M$ 73.00K$ 0.00$ 0.00
Operating Expenses
$ 16.76M$ 18.08M$ 22.27M$ 25.26M$ 25.83M
Depreciation and Amortization
$ 616.88K$ 607.00K$ 615.00K$ 571.00K$ 344.00K
EBITDA
$ -8.65M$ -9.79M$ -21.40M$ -22.57M$ -24.21M
Operating Income
$ -9.26M$ -14.73M$ -22.20M$ -25.26M$ -25.83M
Other Income/Expenses
$ 620.89K$ 3.38M$ -718.00K$ 1.32M$ 1.12M
Pretax Income
$ -8.64M$ -11.36M$ -22.91M$ -23.94M$ -24.71M
Net Income
$ -7.73M$ -10.57M$ -22.13M$ -23.17M$ -24.53M
Per Share Metrics
Basic EPS
$ -1.21$ -9.80$ -32.40$ -39.20$ -50.40
Diluted EPS
$ -1.21$ -9.80$ -32.40$ -39.20$ -50.40
Weighted Average Shares Outstanding
 6.41M 1.07M 683.39K 590.97K 487.33K
Weighted Average Shares Outstanding (Diluted)
 6.41M 1.07M 683.39K 590.97K 487.33K
Currency in USD

Evaxion Biotech Earnings and Revenue History